Total amount raised
$7.5 Millions
Latest funding date
January, 2023
Location
Capsule has successfully raised $70 million in its latest Series D funding round, attracting investment from notable firms such as Baillie Gifford and Durable Capital Partners. The company is focused on revolutionizing the pharmacy industry through innovative healthcare technology.
Keep reading to explore the intricacies of Capsule's fundraising journey and the investors backing this transformative platform.
What Is Capsule?
Capsule, founded in May 2016 by Eric Kinariwala, is a healthcare technology company based in New York, New York. The company aims to revolutionize the pharmacy industry by creating an emotionally resonant experience and leveraging technology to deliver customized outcomes for doctors, hospitals, insurers, and manufacturers.
With a workforce of 501-1000 employees, Capsule is dedicated to rebuilding the pharmacy from the inside out. The company's innovative approach focuses on enhancing the overall healthcare experience through advanced technology and personalized service.
For more detailed information about Capsule, you can visit their Crunchbase profile.
How Much Funding Has Capsule Raised?
- Series A (Oct 14, 2016)
- Amount Raised: Not publicly disclosed
- Date: October 2016
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To establish the company's initial operations and market presence.
- Series A (May 10, 2017)
- Amount Raised: $20M
- Date: May 2017
- Lead Investors: Thrive Capital
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand the company's service offerings and enhance its technology platform.
- Series B (Aug 9, 2018)
- Amount Raised: $50M
- Date: August 2018
- Lead Investors: Glade Brook Capital Partners, Thrive Capital
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To scale operations and enter new markets.
- Series C (Sep 13, 2019)
- Amount Raised: $200M
- Date: September 2019
- Lead Investors: TCV
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand the pharmacy business to other states.
- Series D (Apr 28, 2021)
- Amount Raised: $300M
- Date: April 2021
- Lead Investors: Durable Capital Partners
- Valuation at Round: Surpassed $1 billion
- Motivation Behind the Round: To build out an online marketplace for digital health solutions.
Total Amount Raised: $570M. Current Valuation: Surpassed $1 billion.
Key Investors
- Durable Capital Partners
- Details: Durable Capital Partners is an investment firm focused on long-term growth opportunities. They led Capsule's Series D funding round, contributing $300 million.
- Investment Focus Areas: Technology, healthcare, consumer sectors.
- Notable Investments: Not publicly disclosed.
- Baillie Gifford
- Details: Baillie Gifford is a renowned investment management firm based in Edinburgh, Scotland. They participated in Capsule's Series D funding round.
- Investment Focus Areas: Technology, healthcare, consumer goods.
- Notable Investments: Tesla, Amazon, Spotify.
- Thrive Capital
- Details: Thrive Capital is a venture capital firm founded by Joshua Kushner. They led Capsule's Series A funding round in May 2017.
- Investment Focus Areas: Technology, healthcare, financial services.
- Notable Investments: Instagram, Stripe, Robinhood.
- Glade Brook Capital Partners
- Details: Glade Brook Capital Partners is an investment firm that focuses on high-growth companies. They co-led Capsule's Series B funding round.
- Investment Focus Areas: Technology, consumer internet, healthcare.
- Notable Investments: Airbnb, DoorDash, Instacart.
- TCV
- Details: TCV is a leading growth equity firm that invests in technology companies. They led Capsule's Series C funding round.
- Investment Focus Areas: Technology, healthcare, financial services.
- Notable Investments: Netflix, Facebook, Spotify.
What's Next for Capsule?
Capsule's future looks promising as it aims to build an online marketplace for digital health services, expand its pharmacy business to other states, and develop APIs for healthcare companies. With a recent $300 million funding round, the company is well-positioned to capitalize on the growing demand for digital health solutions and same-day prescription delivery services.
As Capsule continues to grow, future fundraising opportunities seem likely, especially given the significant investor confidence demonstrated by its $1 billion valuation. However, the company will face challenges such as competition from major players like Amazon and managing logistics as it expands to new regions.
Use Clay to Get Funding Data
Sales professionals, take advantage of Clay's platform to access comprehensive fundraising data on companies like Capsule and gather other critical business insights. Sign up for free today and elevate your sales strategy with the power of detailed, actionable information.
